These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 31050979)

  • 1. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.
    Kuang L; Zhou W; Jiang Y
    PLoS One; 2021; 16(12):e0260479. PubMed ID: 34855819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Biochemical, Inflammatory Biomarkers and Ultra-Processed Food Consumption in Children with Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.
    Costa PCT; Duarte DB; Viana das Neves TAF; Moraes RCS; Toscano LLT; Arruda Neta ADCP; Baccin Martins VJ; de Brito Alves JL
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.
    Ortiz-López N; Madrid AM; Aleman L; Zazueta A; Smok G; Valenzuela-Pérez L; Poniachik J; Beltrán CJ
    Front Med (Lausanne); 2024; 11():1376148. PubMed ID: 38854668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Intestine Bacterial Overgrowth is associated with increased Campylobacter and epithelial injury in duodenal biopsies of Bangladeshi children.
    Fahim SM; Donowitz JR; Smirnova E; Jan NJ; Das S; Mahfuz M; Gaffar SMA; Petri WA; Marie C; Ahmed T
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012023. PubMed ID: 38536881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and impact of small intestine bacterial overgrowth in biliary atresia patients.
    Wu JF; Tseng PH; Chang HH; Chiang CM; Lin WH; Hsu WM; Chang MH
    Pediatr Res; 2024 Jan; 95(1):302-307. PubMed ID: 37726543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASLD can cause halitosis by small intestinal bacterial overgrowth.
    Qian XX
    Oral Dis; 2024 May; ():. PubMed ID: 38764349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites.
    Alexiou O; Despotis G; Kalambokis G; Tsiakas I; Christaki M; Tsiouris S; Xourgia X; Lakkas L; Markopoulos GS; Kolios G; Kolios D; Tsiara S; Milionis H; Christodoulou D; Baltayiannis G
    Ann Gastroenterol; 2024; 37(3):348-355. PubMed ID: 38779647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease].
    Vakhrushev YM; Lukashevich AP
    Ter Arkh; 2021 Feb; 93(2):169-173. PubMed ID: 36286631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge.
    Stachowska E; Gudan A; Mańkowska-Wierzbicka D; Liebe R; Krawczyk M
    Intern Emerg Med; 2024 Aug; 19(5):1229-1234. PubMed ID: 38499938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study.
    Lira MMP; de Medeiros Filho JEM; Baccin Martins VJ; da Silva G; de Oliveira Junior FA; de Almeida Filho ÉJB; Silva AS; Henrique da Costa-Silva J; de Brito Alves JL
    PLoS One; 2020; 15(8):e0237360. PubMed ID: 32845887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy.
    Mikolasevic I; Delija B; Mijic A; Stevanovic T; Skenderevic N; Sosa I; Krznaric-Zrnic I; Abram M; Krznaric Z; Domislovic V; Filipec Kanizaj T; Radic-Kristo D; Cubranic A; Grubesic A; Nakov R; Skrobonja I; Stimac D; Hauser G
    Int J Clin Pract; 2021 Apr; 75(4):e13947. PubMed ID: 33406286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial.
    Ghetti FF; De Oliveira DG; De Oliveira JM; Ferreira LEVVC; Cesar DE; Moreira APB
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):279-287. PubMed ID: 31517324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge.
    Roszkowska P; Klimczak E; Ostrycharz E; Rączka A; Wojciechowska-Koszko I; Dybus A; Cheng YH; Yu YH; Mazgaj S; Hukowska-Szematowicz B
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of small intestinal bacterial overgrowth.
    Efremova I; Maslennikov R; Poluektova E; Vasilieva E; Zharikov Y; Suslov A; Letyagina Y; Kozlov E; Levshina A; Ivashkin V
    World J Gastroenterol; 2023 Jun; 29(22):3400-3421. PubMed ID: 37389240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis.
    Kanezawa S; Moriyama M; Kanda T; Fukushima A; Masuzaki R; Sasaki-Tanaka R; Tsunemi A; Ueno T; Fukuda N; Kogure H
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
    Stepanov YM; Zavhorodnia NY; Yagmur VB; Lukianenko OY; Zygalo EV
    Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
    BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
    Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
    Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.